MariMed Inc.
MRMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $27 | $36 | $44 |
| - Cash | $7 | $6 | $7 | $7 |
| + Debt | $80 | $87 | $88 | $88 |
| Enterprise Value | – | $108 | $116 | $125 |
| Revenue | $41 | $40 | $38 | $39 |
| % Growth | 2.9% | 4.4% | -2.7% | – |
| Gross Profit | $16 | $16 | $15 | $13 |
| % Margin | 40.1% | 40.5% | 39.9% | 32.6% |
| EBITDA | $4 | $4 | $2 | $2 |
| % Margin | 10.9% | 10.8% | 5.1% | 4.3% |
| Net Income | -$3 | -$1 | -$5 | -$8 |
| % Margin | -7.2% | -3.2% | -14.4% | -21% |
| EPS Diluted | -0.01 | -0.003 | -0.014 | -0.022 |
| % Growth | -203% | 76.9% | 33.5% | – |
| Operating Cash Flow | $3 | $0 | $1 | -$0 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$1 |
| Free Cash Flow | $2 | -$0 | $1 | -$2 |